OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anti-Integrins for the Treatment of Inflammatory Bowel Disease: Current Evidence and Perspectives
John Gubatan, Kian Keyashian, Samuel J. S. Rubin, et al.
Clinical and Experimental Gastroenterology (2021) Vol. Volume 14, pp. 333-342
Open Access | Times Cited: 59

Showing 51-75 of 59 citing articles:

Optimal Management of Patients with Moderate-to-Severe Inflammatory Bowel Disease
Tuğrul Pürnak, Atilla Ertan
Journal of Clinical Medicine (2024) Vol. 13, Iss. 23, pp. 7026-7026
Open Access

Efficacy and safety of vedolizumab in the treatment of patients with inflammatory bowel disease: A systematic review and meta‑analysis of randomized controlled trials
Huijun Tang, Caiqun Bie, Liliangzi Guo, et al.
Experimental and Therapeutic Medicine (2023) Vol. 25, Iss. 6
Open Access | Times Cited: 1

GM-CSF receptor/SYK/JNK/FOXO1/CD11c signaling promotes atherosclerosis
Daisuke Tsukui, Yoshitaka Kimura, Hajime Kono
iScience (2023) Vol. 26, Iss. 8, pp. 107293-107293
Open Access | Times Cited: 1

TO MARKET, TO MARKET–2022: SMALL MOLECULES
Erika Araujo, Ian M. Bell, Alexander J. Burckle, et al.
Medicinal chemistry reviews (2023), pp. 595-710
Closed Access | Times Cited: 1

Acquired hemophilia associated with vedolizumab in a patient with hemorrhagic rectocolitis
Thomas Schiestel
Blood Science (2022) Vol. 5, Iss. 1, pp. 60-61
Open Access | Times Cited: 1

Adsorptive cytapheresis in ulcerative colitis: A non‐pharmacological therapeutic approach revisited
Filippo Vernia, Angelo Viscido, Giovanni Latella
Journal of Clinical Apheresis (2023) Vol. 38, Iss. 6, pp. 746-754
Open Access

Future treatment options for inflammatory bowel disease
Franziska Bertram, Jan Kempski, Samuel Huber
Deleted Journal (2023) Vol. 18, Iss. 6, pp. 432-439
Closed Access

Interaction of the viral infectious agents in the development and exacerbation of the multiple sclerosis
Sina Mahdavi, Mahdi Asghari Ozma, Arezou Azadi, et al.
Infezioni in Medicina (2023) Vol. 31, Iss. 4
Open Access

Role of artificial intelligence in imaging and endoscopy for the diagnosis, monitoring and prognostication of inflammatory bowel disease: a scoping review protocol
Mallory Chavannes, Lynn Kysh, Mariangela Allocca, et al.
BMJ Open Gastroenterology (2023) Vol. 10, Iss. 1, pp. e001182-e001182
Open Access

CROHN’S DISEASE: A REVIEW ON EPIDEMIOLOGY, DIAGNOSIS AND THERAPEUTIC MANAGEMENT
Mohammad Mukim, Mohit Chaturvedi, Rakesh P. Patel, et al.
INDIAN DRUGS (2022) Vol. 59, Iss. 09, pp. 16-28
Closed Access

Previous Page - Page 3

Scroll to top